Therapeutics: Tumor necrosis factor receptor superfamily member 4 (OX40; TNFRSF4; CD134)

Autoimmune disease

INDICATION: Multiple sclerosis (MS)

Mouse studies suggest agonizing OX40 could help treat MS. In

Read the full 142 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE